Enfusion Inc (NYSE:ENFN)
$ 10.3 -0.17 (-1.62%) Market Cap: 972.03 Mil Enterprise Value: 987.16 Mil PE Ratio: 257.50 PB Ratio: 13.73 GF Score: 64/100

Q2 2024 Enfusion Inc Earnings Call Transcript

Aug 06, 2024 / 12:30PM GMT
Release Date Price: $7.97 (-7.86%)
Operator

Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to Enfusion's second-quarter 2024 earnings conference call. (Operator Instructions) As a reminder, this conference call is being recorded.

Now, I'd like to turn the call over to Bill Wright, Head of Investor Relations to begin.

Bill Wright
Enfusion Inc - Managing Director - Investor Relations

Good morning and thank you, operator. We welcome you to Enfusion's second-quarter 2024 earnings conference call. Hosting today's call are Oleg Movchan, Enfusion's Chief Executive Officer; Brad Herring, Enfusion's Chief Financial Officer; and Neal Pawar, Enfusion's Chief Operating Officer.

Please note our quarterly shareholder letter, which includes our quarterly financial results has been posted to our Investor Relations website.

I would like to remind you that today's call may contain forward looking statements. These forward-looking statements are subject to numerous risks and uncertainties, including those set forth in our filings with the SEC, which are available in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot